First National Corp Solid Biosciences Inc. Transaction History

First National Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Jul 30, 2019	SELL	$4.6 - $10.13 $4,600 - $10,130	-1,000 Closed	0 $0
Q4 2018 Jun 12, 2019	BUY	$21.32 - $46.34 $21,320 - $46,340	1,000 New	1,000 $27,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $29.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

Stay updated on First National Corp with notifications on news.